782041008: Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Hydrolase inhibitor-containing product\Product containing phosphodiesterase inhibitor (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Hydrolase inhibitor-containing product\Product containing phosphodiesterase inhibitor (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing opioid receptor agonist (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing opioid receptor agonist (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Medicinal product categorized by structure (product)\Product containing alkaloid (product)\...

\Opium alkaloid (substance)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\...

\Product containing only papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Product containing scopolamine (medicinal product)\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Product manufactured as parenteral dose form\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Autonomic drug (substance)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\...

\Product containing papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine (medicinal product)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3752376017 Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3752377014 Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3752378016 Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3752376017 Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3752377014 Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3752378016 Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator value	15.4	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mcg	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator unit (attribute)	Milliliter (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has manufactured dose form	Injection solution (product)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Count of base of active ingredient	deux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator unit (attribute)	Milliliter (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mg	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has basis of strength substance (attribute)	Hyoscine hydrobromide	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has basis of strength substance (attribute)	Papaveretum (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Hyoscine hydrobromide	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Is a	Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator value	400	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Papaveretum (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has basis of strength substance (attribute)	Hyoscine hydrobromide	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Papaveretum (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mcg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Hyoscine hydrobromide	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has basis of strength substance (attribute)	Papaveretum (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3752376017	Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3752377014	Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752378016	Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752376017	Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3752377014	Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752378016	Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core